![]()
|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print March 21, 2001
Department of Medicine, Toronto General Hospital, Toronto, Ontario M5G2C4
Corresponding Author: d.drucker{at}utoronto.ca
Glucagon-like peptide-2 (GLP-2) is expressed in gut endocrine cells where it regulates energy homeostasis via effects on nutrient absorption, and maintenance of mucosal epithelial integrity. The biological actions of GLP-2 in the central nervous system (CNS) remain poorly understood. We studied the sites of endogenous GLP-2 receptor (GLP-2R) expression, the localization of transgenic LacZ expression under the control of the mouse GLP-2R promoter and the biological actions of GLP-2 in the murine CNS. GLP-2R expression was detected in multiple extrahypothalamic regions of the mouse and rat CNS including cell groups in the cerebellum, medulla, amygdala, hippocampus, dentate gyrus, pons, cerebral cortex and pituitary. A 1.5-kilo base-pair fragment of the mouse GLP-2R promoter directed LacZ expression to the gastrointestinal tract and CNS regions in the mouse that exhibited endogenous GLP-2R expression including the cerebellum, amygdala, hippocampus and dentate gyrus. Intracerebroventricular injection of GLP-2 significantly inhibited food intake during dark phase feeding in wildtype mice. Disruption of glucagon-like peptide-1 (GLP-1) receptor signaling with the antagonist exendin (9-39) in wildtype mice, or genetically in GLP-1 receptor -/- mice, significantly potentiated the anorectic actions of GLP-2. These findings illustrate that CNS GLP-2R expression is not restricted to hypothalamic nuclei, and demonstrate that the anorectic effects of GLP-2 are transient and modulated by the presence or absence of GLP-1 receptor signaling in vivo.
J. Biol. Chem, 10.1074/jbc.M009382200
Submitted on October 13, 2000
Revised on March 19, 2001
Accepted on March 20, 2001
Glucagon-like peptide-2 action in the murine central nervous system is enhanced by elimination of GLP-1 receptor signaling
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
F. Yi, J. Sun, G. E. Lim, I. G. Fantus, P. L. Brubaker, and T. Jin Cross Talk between the Insulin and Wnt Signaling Pathways: Evidence from Intestinal Endocrine L Cells Endocrinology, May 1, 2008; 149(5): 2341 - 2351. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. McDonagh, J. Lee, A. Izzo, and P. L. Brubaker Role of glial cell-line derived neurotropic factor family receptor {alpha}2 in the actions of the glucagon-like peptides on the murine intestine Am J Physiol Gastrointest Liver Physiol, August 1, 2007; 293(2): G461 - G468. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. Dube and P. L. Brubaker Frontiers in glucagon-like peptide-2: multiple actions, multiple mediators Am J Physiol Endocrinol Metab, August 1, 2007; 293(2): E460 - E465. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Estall and D. J. Drucker Tales beyond the Crypt: Glucagon-Like Peptide-2 and Cytoprotection in the Intestinal Mucosa Endocrinology, January 1, 2005; 146(1): 19 - 21. [Full Text] [PDF] |
||||
![]() |
J. L. Estall, B. Yusta, and D. J. Drucker Lipid Raft-dependent Glucagon-like Peptide-2 Receptor Trafficking Occurs Independently of Agonist-induced Desensitization Mol. Biol. Cell, August 1, 2004; 15(8): 3673 - 3687. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Lovshin, Q. Huang, R. Seaberg, P. L. Brubaker, and D. J. Drucker Extrahypothalamic Expression of the Glucagon-Like Peptide-2 Receptor Is Coupled to Reduction of Glutamate-Induced Cell Death in Cultured Hippocampal Cells Endocrinology, July 1, 2004; 145(7): 3495 - 3506. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Brubaker and D. J. Drucker Minireview: Glucagon-Like Peptides Regulate Cell Proliferation and Apoptosis in the Pancreas, Gut, and Central Nervous System Endocrinology, June 1, 2004; 145(6): 2653 - 2659. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ramsanahie, M. S. Duxbury, T. C. Grikscheit, A. Perez, D. B. Rhoads, J. Gardner-Thorpe, J. Ogilvie, S. W. Ashley, J. P. Vacanti, and E. E. Whang Effect of GLP-2 on mucosal morphology and SGLT1 expression in tissue-engineered neointestine Am J Physiol Gastrointest Liver Physiol, December 1, 2003; 285(6): G1345 - G1352. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Estall and D. J. Drucker Dual Regulation of Cell Proliferation and Survival via Activation of Glucagon-Like Peptide-2 Receptor Signaling J. Nutr., November 1, 2003; 133(11): 3708 - 3711. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Walsh, B. Yusta, M. P. DaCambra, Y. Anini, D. J. Drucker, and P. L. Brubaker Glucagon-Like Peptide-2 Receptor Activation in the Rat Intestinal Mucosa Endocrinology, October 1, 2003; 144(10): 4385 - 4392. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Mayo, L. J. Miller, D. Bataille, S. Dalle, B. Goke, B. Thorens, and D. J. Drucker International Union of Pharmacology. XXXV. The Glucagon Receptor Family Pharmacol. Rev., March 1, 2003; 55(1): 167 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Ni, Y. Anini, X. Fang, G. Mills, P. L Brubaker, and T. Jin Transcriptional Activation of the Proglucagon Gene by Lithium and beta -Catenin in Intestinal Endocrine L Cells J. Biol. Chem., January 3, 2003; 278(2): 1380 - 1387. [Abstract] [Full Text] [PDF] |
||||
![]() |
D J Drucker Gut adaptation and the glucagon-like peptides Gut, March 1, 2002; 50(3): 428 - 435. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bjerknes and H. Cheng Modulation of specific intestinal epithelial progenitors by enteric neurons PNAS, September 19, 2001; (2001) 211278098. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bjerknes and H. Cheng Modulation of specific intestinal epithelial progenitors by enteric neurons PNAS, October 23, 2001; 98(22): 12497 - 12502. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |